Barclays »

Adicet Bio Ord shares owned by Barclays

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $211k 25k 8.42

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corp Opt Put Option (MSFT)
Apple (AAPL)
Ishares Tr Opt Call Option (IWM)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
Facebook Inc cl a (META)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Opt Put Option (HYG)
Advanced Micro Devices (AMD)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Adicet Bio Ord

Franklin Resources
Vanguard Group
Renaissance Technologies
Goldman Sachs Group
Stonepine Capital Management
Alyeska Investment Group
Acadian Asset Management
ADAR1 Capital Management
Geode Capital Management
Luminus Management
State Street Corporation
Barclays
GSA Capital Partners
FNY Investment Advisers
UBS Group

View all funds holding Adicet Bio Ord